References
- National Institute of Drug Abuse, https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. Accessed September 10, 2018.
- US Centers for Disease Control and Prevention. Understanding the Epidemic. Available at: https://www.cdc.gov/drugoverdose/epidemic/index.html. Accessed September 10, 2018.
- Ossiander EM. Using textual cause-of-death data to study drug poisoning deaths. Am J Epidemiol. 2014;179(7):884–94.
- Suzuki T, Ohmuro A, Miyata M, Furuishi T, Hidaka S, Kugawa F, Fukami T, Tomono K. Involvement of an influx transporter in the blood-brain barrier transport of naloxone. Biopharm Drug Dispos. 2010;31(4):243–52.
- American Society of Addiction Medicine. Public Policy Statement on the Use of Naloxone for the Prevention of Opioid Overdose Deaths. Available at: https://www.asam.org/advocacy/find-a-policy-statement/view-policy-statement/public-policy-statements/2014/08/28/use-of-naloxone-for-the-prevention-of-drug-overdose-deaths.
- Adams JM. Surgeon General’s Advisory on Naloxone and Opioid Overdose, https://www.surgeongeneral.gov/priorities/opioid-overdose-prevention/naloxone-advisory.html, Accessed September 10, 2018
- US Food and Drug Administration, Center for Drug Evaluation and Research, Summary review for regulatory action of Evzio New Drug Application. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/209862Orig1s000SumR.pdf. Accessed September 10, 2018.
- USP Monograph, Naloxone HCl Injection Monograph, 2018, USP41-NF36:2856
- Bahal SM, Wu, L-S, Stabilized naloxone formulations. United States patent US 5,866,154. 1999 Feb 2.
- Altannak NF. Liquid chromatography-mass spectrometry method to assess naloxone hydrochloride photostability under artificial light and sunlight exposure at room temperature. Asian J Pharm Clin Res. 2015;8(5):290–92.
- Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites. Clin Pharmacol Ther. 2006;79(5):461–79. doi:10.1016/j.clpt.2006.01.009.
- Codd EE, Shank RP, Schupsky, JJ, Raffa RB. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther. 1995;274(3):1263–70.
- Lemberg KK, Siiskonen AO, Kontinen VK, Yli-Kauhaluoma JT, Kalso EA. Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia. Anesth Analg. 2008;106(2):463–70.
- World Health Organization. Accelerated stability studies of widely used pharmaceutical substances under simulated tropical conditions. Available at: http://apps.who.int/medicinedocs/en/d/Jh1808e/. Accessed September 10, 2018.
- Khan SR, Kona R, Faustino PJ, Gupta A, Taylor JS, Porter DA, Khan M. The rising price of naloxone - risks to efforts to stem overdose deaths. J Pharm Sci. 2014;103(5):1331–6.
- U.S. Department of Health and Human Services, 5-Point Strategy To Combat the Opioid Crisis https://www.hhs.gov/opioids/about-the-epidemic/hhs-response/index.html, Accessed September 10, 2018.
- Gupta, R., Shah, N. D., Ross, J. S. (2016). The rising price of naloxone- risks to efforts to stem overdose deaths. New Eng J Med. 375(23), 2213–2215.